Columbia Trust’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $1.11M | Buy |
1,265
+142
| +13% | +$125K | 0.5% | 62 |
|
|
2023
Q3 | $924K | Buy |
1,123
+9
| +0.8% | +$7.41K | 0.54% | 60 |
|
|
2023
Q2 | $800K | Buy |
1,114
+7
| +0.6% | +$5.03K | 0.45% | 64 |
|
|
2023
Q1 | $910K | Sell |
1,107
-38
| -3% | -$31.2K | 0.53% | 56 |
|
|
2022
Q4 | $826K | Buy |
1,145
+33
| +3% | +$23.8K | 0.46% | 65 |
|
|
2022
Q3 | $766K | Buy |
1,112
+140
| +14% | +$96.4K | 0.43% | 67 |
|
|
2022
Q2 | $575K | Buy |
972
+505
| +108% | +$299K | 0.31% | 80 |
|
|
2022
Q1 | $342K | Buy |
+467
| New | +$342K | 0.16% | 119 |
|